CEO’s Insider Sales at NexGel Raise Questions About Company’s Valuation
CEO insider sales at NexGel Inc. raise questions about its future. 24,000 shares sold at $0.55–$0.61 could signal liquidity needs or a bearish outlook for the small‑cap biotech firm.
4 minutes to read